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Weissella spp. are non-spore forming, catalase-negative, gram-positive coccobacilli.
They are often misidentified by traditional and commercial phenotypic identification
methods as Lactobacillus spp. or Lactobacillus-like organisms. Weissella spp. were
previously grouped along with Lactobacillus spp., Leuconostoc spp., and Pediococcus
spp. Utilization of more sensitive methods like DNA sequencing or Matrix-Assisted Laser
Desorption/Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS) has facilitated
identification of Weissella as a unique genus. Nineteen species have been identified
to date. W. confusa, W. cibaria, and W. viridescens are the only species isolated from
humans. The true prevalence ofWeissella spp. continues to be probably underestimated.
Weissella spp. strains have been isolated from a wide range of habitats including raw
milk, feces, fermented cereals, and vegetables.Weisella is believed to be a rare cause of
usually nonfatal infections in humans, and is often considered a contaminant. However, in
recent years, Weissella spp. have been implicated in bacteremia, abscesses, prosthetic
joint infections, and infective endocarditis. Alterations of the gut flora from surgery or
chemotherapy are believed to facilitate translocation of Weissella spp. due to disruption
of the mucosal barrier, predisposing the host to infection with this organism. Implications
of the isolation ofWeissella spp. from blood must be interpreted in context of underlying
risk factors. Weissella spp. are inherently resistant to vancomycin. Therefore, early
consideraton of the pathogenic role of this bacteria and choice of alternate therapy is
important to assure better outcomes.
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INTRODUCTION
Weissella spp. are non-spore forming, hetero-fermentative, facultative anaerobic, gram-positive,
catalase-negative, alpha hemolytic bacteria that appear as short rods or coccobacilli in pairs and
chains (Collins et al., 1993; Olano et al., 2001; Björkroth et al., 2009). Based on their unusual Gram
stain morphology and inherent resistance to vancomycin,Weissella spp. have been often confused
with Lactobacillus spp. or Lactobacillus-like organisms. They are usually considered contaminants
when recovered from clinical specimens and rarely identified to the species level due to their
fastidious nature (Facklam et al., 1989; Facklam and Elliott, 1995; Kumar et al., 2011).
Weissella was identified as a unique genus in 1993 on the basis of 16S rRNA gene sequence
analysis and named after Norbert Weiss, a German microbiologist, for his many contributions to
the taxonomy of lactic acid bacteria (Collins et al., 1993). Leuconostoc paramesenteroides and related
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species amongst the catalase-negative, vancomycin-resistant,
gram-positive cocci were reclassified into this genus. Weissella
now constitute a distinct phylogenetic group, separate from those
of other genera of lactic acid bacteria, including Leuconostoc,
Lactobacillus, and Streptococcus (Flaherty et al., 2003). To date,
nineteen species of Weissella have been identified, namely: W.
beninensis, W. ceti, W cibaria, W. confusa, W. diestrammenae,
W. fabalis, W. fabaria, W. ghanensis, W. halotolerans, W.
hellenica, W. kandleri, W. koreensis, W. minor, W. oryzae,
W. paramesenteroides, W. soli, W. thailandensis, W. uvarum, W.
viridescens (Fusco et al., 2015). All species except W. beninensis
are non-motile (Padonou et al., 2010; Björkroth et al., 2014).
Of these, only W. confusa (previously Lactobacillus confusus),
W. cibaria, and W. viridescens have been isolated from human
clinical specimens (Björkroth et al., 2002; Kulwichit et al., 2007;
Fusco et al., 2015) and considered as opportunistic pathogens
(Fusco et al., 2015). W. confusa has also been documented as a
cause of systemic infection in a healthy primate (Cercopitheus
mona; Vela et al., 2003) and neonatal sepsis in a foal (Lawhon
et al., 2014). W. confusa and W. cibaria both have the ability to
produce NH3 from arginine but differ in their ability to acidify
different sugars (Björkroth et al., 2002). Unlike W. confusa, W.
cibara is negative for the fermentation of galactose and xylose
and positive for the fermentation of arabinose (Björkroth et al.,
2002). Several species of Weissella, including some strains of W.
confusa, can grow at 25, 35, and 45◦C (Olano et al., 2001; Vasquez
et al., 2015).Weissella species have been used in the production of
a variety of fermented foods and beverages and also as probiotics
(Kang et al., 2011; Lee et al., 2012; Gomathi et al., 2014; Zhang
et al., 2014).W. cibaria possesses anti-cancer, anti-inflammatory,
antibacterial, anti-fungal, and immune boosting potential (Nam
et al., 2002; Kang et al., 2006; Srionnual et al., 2007; Lee et al.,
2008, 2013; Valerio et al., 2009; Ahn et al., 2013; Kwak et al., 2014).
EPIDEMIOLOGY
Weissella spp. have a widespread distribution and have been
isolated from a wide variety of habitats including raw milk,
feces, saliva, breast milk, urine, fermented cereals, meat and meat
products, sugar cane, carrot juice, banana leaves and vegetables
(Kandler and Weiss, 1986; Björkroth et al., 2002; Fairfax et al.,
2014; Fusco et al., 2015). They have also been recovered from
feces of healthy individuals (Green et al., 1990; Walter et al.,
2001) and are common inhabitants of the vaginal microbiota
(Jin et al., 2007). Although Weissella are of rare occurrence in
humans, several disease outbreaks involving W. ceti have been
reported in cultured rainbow trout from geographically diverse
locations (United States, China, Brazil; Liu et al., 2009; Figueiredo
et al., 2012; Welch and Good, 2013; Costa et al., 2015). The
true incidence of Weissella infection in humans is probably
underestimated due to its misidentification.
DIAGNOSIS
Identification of Weissella at the genus and species level has
been challenging. It is often misidentified as Lactobacillus-like or
viridans streptococci and accurate identification is not possible by
traditional or commercial phenotypic identificationmethods that
include morphological analysis, growth characteristics and sugar
fermentation profiles as these techniques have low taxonomic
discrimination (Fusco et al., 2015). Commercial biochemical
based identification kits namely API (Analytical Profile Index
systems, bioMéreiux, France) and RapiID Strep panel (Remel,
USA) are unable to identify Weissella species. The identification
table of API 20 Strep does not include Weissella. API 50 CHL
kit (version 5.1) has W. confusa and W. viridescens in its
identification table; however, it cannot differentiate W. cibara
from W. confusa (Kulwichit et al., 2007). RapID™ STR System
does include W. confusa in its database but only give a high
probability result (Fairfax et al., 2014). Automated systems
namely Vitek 2 (bioMéreiux, France), MicroScan (Beckman
Coulter Inc. USA), and Phoenix Automated Microbiology
System (BD Diagnostic Systems, USA), do not have Weissella
in their database and as such cannot reliably identify Weissella
species (Lee et al., 2011; Fairfax et al., 2014; Fusco et al.,
2015).
Molecular DNA sequencing involving 16S rRNA gene
sequence analysis can accurately identifyWeissella to the species
level and remains the current gold standard. It has also emerged
as powerful tool for identification of phenotypically atypical
microorganisms (Petti et al., 2005) and has been successfully
used to identify Weissella to the species level (Collins et al.,
1993; Vasquez et al., 2015). Most of the cases of W. confusa
reported were originally misidentified as Lactobacillus-like
or viridians streptococci organisms by phenotypic methods.
These were subsequently confirmed to be W. confusa using
16S rRNA gene sequence analysis. Amplified ribosomal DNA
restriction analysis (ARDRA; Jang et al., 2002) and ribotyping
(Björkroth et al., 2002) have also been used to correctly
identify Weissella species. Molecular typing techniques for
Weissella species include DNA finger printing and restriction
of ribosomal DNA (Villani et al., 1997), numerical analysis of
HindIII and EcoRI ribopatterns (Koort et al., 2006), repetitive
element-PCR fingerprinting using (GTG)5-PCR (Bounaix
et al., 2010), and fluorescent- amplified fragment length
polymorphism (fAFLP; Fusco et al., 2011). MALDI-TOF MS
is now being routinely used for the identification of bacterial
organisms (Bizzini et al., 2010; Wieser et al., 2012) and can
also accurately identify W. confusa (Lee et al., 2013; Fairfax
et al., 2014). Two MALDI-TOF MS systems have found
increasing use in microbiology laboratories and both are
sensitive for the identification of unusual and/or difficult-
to-identify microorganisms isolated from clinical specimens
(McElvania TeKippe and Burnham, 2014). The Bruker Biotyper
(Bruker Daltonics, Germany) software version 3.0 also includes
W. confusa, W. halotolerans, W. minor, and W. viridescens,
and VITEK MS (bioMérieux, France) database v2.0 has W.
confusa and W. viridescens. The future versions of both these
mass spectrometry systems are likely to incorporate other
Weissella spp. which will facilitate their early identification
and provide insight into the true prevalence of these
infections.
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PREDISPOSING FACTORS AND CLINICAL
MANIFESTATIONS
Most of the cases of W. confusa infections reported in humans
have been from immunocompromised patients (Lahtinen
et al., 2012; Fairfax et al., 2014; Medford et al., 2014).
Malignancy has been the most common factor associated with
immunocompromised and complicated medical status. Recent
chemotherapy, organ transplant, burn, chronic alcoholism, long-
term use of steroids, chronic renal insufficiency and diabetes
seem to increase the chances of acquiring this infection
(Flaherty et al., 2003; Salimnia et al., 2011; Table 1). Orthopedic
procedures like joint replacements, arthroplasty, and post-
operative osteomyelitis also put the patients at increased risk of
bacterial infections. Prior exposure to vancomycin may results
in the selection of Weissella, which is intrinsically resistant to
this drug. Central line catheter insertion prior to any surgical
procedure increases the risk of infection, although Weissella
has not been recovered from catheter tips. Total parenteral
nutrition has been suspected to be risk factor for the development
of bacteremia involving Weissella species (Olano et al., 2001;
Flaherty et al., 2003; Kumar et al., 2011; Lee et al., 2011; Vasquez
et al., 2015). Weissella is a common inhabitant of the human
gastrointestinal system. A compromise of the gastrointestinal
mucosal barrier due to surgery is associated with increased risk
of acquiring this infection and may be a probable route of
entry of W. confusa resulting in bacteremia and endocarditis
(Flaherty et al., 2003; Shin et al., 2007). Polymicrobial infection
and subsequent antimicrobial measures resulting in the alteration
of gut flora also favor the selection of Weissella in such patients
(Kumar et al., 2011). Changes in the normal flora of the throat,
gut, and vaginal tract and disruption of mucous integrity by
invasive procedures, surgery, and/or antibiotics predispose the
host to increased risk of Weissella infection. The possible risk
factors for W. cibara and W. viridescens infection in humans
remain unknown.
W. confusa has been associated with a variety of clinical
manifestations in humans (Table 1). The majority of the cases
are seen in the settings of polymicrobial infections (Green et al.,
1990, 1991; Bantar et al., 1991; Salimnia et al., 2011). However,
it has also been recovered as the sole microbial agent in certain
cases (Flaherty et al., 2003; Lee et al., 2011). Bacteremia is the
major manifestation of W. confusa infection in humans (Olano
et al., 2001; Kulwichit et al., 2007; Svec et al., 2007; Harlan et al.,
TABLE 1 | Summary of previously documentedWeissella confusa infections.
Age (year, sex) Clinical infection Underlying conditions Treatment** Survival References
71,M Peritoneal fluid Hemicolectomy Cephalosporin Survived Riebel and Washington, 1990
12, F Abdominal fluid Gastrostomy Cephalosporin Survived Riebel and Washington, 1990
49,M Thumb abscess Palm tree splinter in thumb CEF Survived Bantar et al., 1991
46,M Bacteremia Abdominal surgery, polymicrobial infection PIP-TAZ, VAN/GENT Survived Olano et al., 2001
49,M Endocarditis Alcoholism, previous steroid use, carious
teeth
None Died Flaherty et al., 2003
65,M Endocarditis Aortic insufficiency PEN, GENT, MXF, CEF Survived Shin et al., 2007
Unknown, F Osteomyelitis Surgery, bone grafting of mandible AMP-SUL Unknown Kulwichit et al., 2008
4,M Bacteremia Peritoneal neuroblastoma, CT, ileus surgery MEM, AZT, CXT, MTZ, TEC Survived Svec et al., 2007
Multiple cases* Bacteremia Malignancy (4), CT (3), chronic steroid use (3),
abdominal surgery (4), polymicrobial infection
(5), central catheter (6)
Miscellaneous** Survived (4),
Died (6)
Lee et al., 2011
34,M Bacteremia ALL, ASCT VAN, AZT then DAP Survived Salimnia et al., 2011
52,M Bacteremia Severe burns, polymicrobial infection, central
catheter
VAN, IPM then DAP Survived Salimnia et al., 2011
54,M Bacteremia HCC/liver transplant, diabetes VAN, PIP-TAZ then CTX/LVX,
MTZ
Survived Harlan et al., 2011
48,M Bacteremia Gastro-esophageal adenocarcinoma, CT,
Endoscopy
CFP- SUL, MTZ Survived Kumar et al., 2011
60, F Bacteremia Intramural hematoma of the aorta CTX then TEI and PIP-TAZ Survived Lee et al., 2013
94, F Prosthetic joint Osteoarthritis, total knee arthroplasty LVX Survived Medford et al., 2014
63, F Bacteremia Multiple abdominal surgeries, central catheter DAP Survived Vasquez et al., 2015
HCC, hepatocellular carcinoma; ALL, acute lymphocytic leukemia; ASCT, autologous stem cell transplant; AHSCT, autologous hematopoietic stem cell transplant; CT, chemotherapy;
TPN, total parenteral nutrition.
AMP, ampicillin; AZT, aztreonam; CEF, cephalothin; CFP, cefoperazone; CTX, ceftriaxone; CXT, cefoxitin; DAP, daptomycin; GENT, gentamicin; IPM, imipenem; LVX, levofloxacin; MEM,
meropenem; MXF, moxifloxacin; MTZ, metronidazole; PEN, penicillin; PIP-TAZ, piperacillin-tazobactam; SUL, sulbactam; TEC, teicoplanin; VAN, vancomycin.
M, male; F, female.
*6 females and 4 males with average age of 56.6 years.
**Ampicillin-sulbactam (2), amoxicillin –clavulanate (3), ceftazidime (3), cefepime (1), combined therapy with trimethoprim/sulfamethoxazole, vancomycin, ciprofloxacin & ceftazidime (1).
After empiric therapy, antibiotics were adjusted to ampicillin-sulbactam (2), piperacillin-sulbactam (1), amoxicillin-clavulanate (1), piperacillin-tazobactam (1), penicillin (1). One patient did
not receive any antibiotic (1).
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TABLE 2 | Minimum Inhibitory Concentrations (MICs, in µg/mL) ofWeissella confusa to various antibiotics.
Antibiotic Bantar et al., 1991
n = 1
Olano et al., 2001
n = 1
Vay et al., 2007
n = 2
Svec et al., 2007
n = 1
Lee et al., 2011
n = 10
Medford et al., 2014
n = 2
Amikacin – – 8 – – –
Amoxicillin-clavulanate – – – – 0.5–8/0.25–4 –
Amoxicillin – 1 – – – –
Ampicillin 0.5 – 0.5 0.5 0.5–1 0.5
Ampicillin-sulbactam – – – – 8–16/2–4 –
Azithromycin – – – – 0.12 –
Cefotaxime 4 – – 3 – –
Cefoxitin 32 – – – – –
Ceftazidime 16 – – – ≥128 –
Ceftobiprole – – – – 0.5–2 –
Ceftriaxone – 4 16–64 – – –
Cefuroxime 8 4 8 – – –
Cephalothin 8 – 8 – – –
Chloramphenicol 8 – 1 – – 4–8
Ciprofloxacin 1 – 8 0.5 – ≤1–2
Clindamycin – ≤0.1 – 0.06 – ≤0.5
Cotrimoxazole – – – >32 – –
Daptomycin – – – – 0.03–0.12 ≤0.5
Doripenem – – – – 0.5–16 –
Erythromycin ≤0.125 ≤0.12 0.032–0.063 0.13 – ≤0.25
Gatifloxacin – – 0.5–1 – – –
Gentamycin 1 – 8 3 – ≤0.2
Imipenem ≤0.125 – 0.125 0.06 – –
Levofloxacin – – 4–8 – – 2
Linezolid – – 2–4 – 2–4 2–4
Meropenem – – – – 1–16 –
Metronidazole – – – >256 – –
Moxifloxacin – – – 0.25–0.5 0.5
Penicillin 1 0.5 0.25 0.38 – 0.5
Piperacillin – – 4 – – –
Piperacillin-tazobactam – – – – 4–8/4 –
Rifampin >8 – 64 – – –
Tigecycline – – – – 0.03–0.12 –
Teicoplanin – – ≥512 >256 – –
Tetracycline – 4 – – – 4–8
Trimethoprim-sulfamethoxazole >64 >4 128–256 – 16–≥128 >4
Vancomycin >256 >16 ≥512 >256 >64 Resistant
2011; Lee et al., 2011, 2013; Salimnia et al., 2011; Vasquez et al.,
2015). Other clinical vignettes in which this organism has been
reported include endocarditis (Flaherty et al., 2003; Shin et al.,
2007), post-operative osteomyelitis (Kulwichit et al., 2008), and
abscess (Bantar et al., 1991). It has also been recovered from
peritoneal fluid and the abdominal wall (Riebel andWashington,
1990) and infected prosthetic joint (Medford et al., 2014).
W. cibaria have been identified in the urine, lung, and
blood of patients with bacteremia. W. viridescens has been
recovered from human blood (Kulwichit et al., 2007) and fecal
DNA from children with celiac disease (Sanz et al., 2007). The




Weissella is known to be intrinsically resistant to vancomycin
and has high minimum inhibitory concentration (MIC)
of ≥256µg/ml. Antimicrobial susceptibilities of W. confusa
are not fully understood. There are no standard methods
and interpretation criteria of antimicrobial susceptibilities
established so far for Weissella spp. by the Clinical and
Laboratory Standards Institute (CLSI). Susceptibility testing
methods have included broth dilution, agar based methods
(Bantar et al., 1991; Olano et al., 2001; Vay et al., 2007; Lee et al.,
2011; Medford et al., 2014) and E-test (Svec et al., 2007; Table 2).
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LowMICs have been noted for penicillin, ampicillin, tetracycline,
clindamycin, erythromycin, ciprofloxacin, daptomycin,
imipenem, fluoroquinolones (levofloxacin, moxifloxacin),
amoxicillin-clavulanate, ampicillin-sulbactam, piperacillin-
tazobactam, and doripenem. W. confusa exhibits a high
level of resistance to ceftazidime, cotrimoxazole, rifampin,
metronidazole, teicoplanin and trimethoprim/sulfamethoxazol.
CONCLUSION
W. confusa is an opportunistic bacterial organism that warrants
rapid and accurate identification to ensure appropriate therapy.
It is difficult to distinguish Weissella species from other
heterofermentative bacteria on the basis of phenotypic or
biochemical tests alone. Accurate and rapid identification to the
species level is feasible using 16S rRNA or MALDI-TOF MS
techniques. Infections with Weissella spp. primarily occur in
immunocompromised status and/or those with other underlying
medical conditions. It is a common inhabitant of the gut flora,
therefore, surgical procedures may translocate this organism
and result in bacteremia, endocarditis, and abscess formation.
The clinical significance of W. confusa remains unclear in the
setting of polymicrobial infections, which comprise the largest
proportion of total cases. The use of antimicrobial agents,
especially vancomycin, may predispose patients to increased risk
of infection with Weissella, which is intrinsically resistant to
this drug (Lahtinen et al., 2012; Fairfax et al., 2014; Medford
et al., 2014). When isolated in blood culture, Weissella may be
confused with Lactobacillus-like or viridians streptococci and can
be considered a probable contaminant (Ruoff, 2002; Fairfax and
Salimnia, 2012; Fairfax et al., 2014). However, Weissella is not a
part of the normal skin flora and should be considered significant
when isolated from blood cultures (Petti et al., 2005).
Vancomycin is the empiric first-line therapy for bacteremia
caused by gram-positive organisms. However, the use of
vancomycin is likely to favor the growth of vancomycin-resistant
organisms and may predispose these patients to subsequent
infections with Weissella and other vancomycin resistant
organisms (Fairfax and Salimnia, 2012). Early consideration
of this organism in the differential diagnosis is important
due to its inherent vancomycin resistance, which necessitates
alternative therapy. Management of positive blood cultures
especially from immunocompromised patients is a challenge
both for the laboratory microbiologists as well as the clinicians.
Penicillin, ampicillin, imipenem, clindamycin, erythromycin,
moxifloxacin, doripenem, daptomycin, and tigecycline are all
therapeutic agents for treating Weissella infections. The use of
vancomycin, metronidazole, rifampin, teicoplanin, ceftazadime,
and trimethoprim-sulphamethoxazole should be avoided if
Weissella spp. is suspected. Antimicrobial susceptibility testing
is vital to guide appropriate therapy in cases of severe
infections.
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